Bio-Techne
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $316,964 | $316,181 | $297,031 | $289,458 |
Gross Profit | 198,812 | 214,556 | 193,886 | 183,017 |
EBITDA | 6,430 | 67,852 | 74,923 | 73,865 |
EBIT | -20,681 | 40,281 | 47,839 | 45,728 |
Net Income | -17,678 | 22,588 | 34,890 | 33,600 |
Net Change In Cash | 316,964 | 316,181 | 297,031 | 289,458 |
Free Cash Flow | 93,311 | 30,997 | 77,525 | 54,717 |
Cash | 162,186 | 140,670 | 177,549 | 187,540 |
Basic Shares | 154,913 | 158,944 | 160,626 | 161,115 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $1,219,635 | $1,159,060 | $1,136,702 | $1,105,599 |
Gross Profit | 790,272 | 769,725 | 769,815 | 756,496 |
EBITDA | 216,875 | 310,371 | 460,565 | 420,116 |
EBIT | 106,972 | 198,660 | 353,327 | 319,047 |
Net Income | 73,400 | 168,105 | 285,263 | 272,051 |
Net Change In Cash | 1,219,635 | 1,159,060 | 1,136,702 | 1,105,599 |
Cost of Revenue | 11,360 | -14,432 | ||
Free Cash Flow | 256,550 | 236,104 | 216,149 | 280,364 |
Cash | 162,186 | 151,791 | 180,571 | 172,567 |
Basic Shares | 159,717 | 160,774 | 161,855 | 164,116 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.53 |
2025-03-31 | $0.56 |
2024-12-31 | $0.42 |
2024-09-30 | $0.42 |
